Menu

WIKIMEDIA, NIH

Francis Collins Pranked by Sacha Baron Cohen

Duped into an interview with the comedian, the NIH director caught on to the joke and seized it as a teaching opportunity.

Aug 24, 2018
Ashley Yeager

A few minutes into an interview with a “journalist” from a Showtime special, Francis Collins, the director of the National Institutes of Health, sensed something wasn’t quite right.

“Why are big agriculture putting chemicals [trans fats] into our food to make people transgender?” asked the interviewer, who called himself Billy Wayne Ruddick Jr., PhD.

“Yeah, that was interesting,” Collins tells reporters, according to STAT News. “That interview was done last November and was presented as a Showtime special where the interviewer is somebody who doesn’t know a lot about medical research, but gives you a chance to talk about the exciting things that are happening at NIH. Sounds like a plausible thing that I’d want to do.”

That’s not exactly what happened, however. “It was pretty clear that this was not the usual circumstance,” Collins says. Ruddick was actually comedian Sacha Baron Cohen in disguise for “Who Is America,” a political satire show. “But I decided, just play it straight. And you saw the result. Actually, you saw three minutes of about an hour of a very interesting conversation.” Collins’s interview with Ruddick aired on Showtime on Sunday (August 19).

The joke on Collins didn’t land perfectly, according to critics. “Sure, some of Cohen’s jokes as Ruddick landed well in this segment, but the world would be a better place if Collins were off studying the human genome instead of wasting his time here,” Josh Modell writes in Vulture.

Collins considered ending the interview early, but, “I thought, maybe there’s a public health message that could get wrapped in here. And there was a bit, about trans fats and needle sharing. So there you go.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384.
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.